This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
17/5 20:42
Key PointsHighVista Strategies sold 69,092 shares of Structure Therapeutics in the first quarter; the estimated transaction value was $4.73 million based on quarterly average prices....